Myocardial Infarction Occurs with a Similar 24h Pattern in the 4G/5G Versions of Plasminogen Activator Inhibitor-1

被引:3
作者
Bergheanu, Sandrin C. [1 ,2 ,3 ]
Pons, Douwe [2 ,3 ]
Jukema, J. Wouter [2 ,3 ,4 ]
van der Hoeven, Bas L. [2 ]
Liem, Su-San [2 ]
Vandenbroucke, Jan P. [1 ]
Rosendaal, Frits R. [1 ,3 ]
le Cessie, Saskia [1 ,5 ]
Schalij, Martin J. [2 ]
van der Bom, Johanna G. [1 ,3 ]
机构
[1] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands
[4] Durrer Inst Cardiogenet Res, Amsterdam, Netherlands
[5] Leiden Univ, Med Ctr, Dept Biostat, NL-2300 RC Leiden, Netherlands
关键词
PAI-1; Genotypes; Cardiovascular risk; Diurnal; Myocardial infarction; SUDDEN CARDIAC DEATH; CIRCADIAN VARIATION; PLASMINOGEN-ACTIVATOR-INHIBITOR-1; GENE; FIBRINOLYTIC-ACTIVITY; MONOCLONAL-ANTIBODY; ARTERIAL THROMBOSIS; DIURNAL-VARIATION; PAI-1; THROMBOLYSIS; CELLS;
D O I
10.1080/07420520902925993
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
PAI-1 expression is regulated by a 4G/5G promoter polymorphism. The 4G allele is associated with greater circadian variation of PAI-1 levels. We hypothesized that the 24h variation of cardiac risk is more pronounced among persons with the 4G4G genotype than among ones with 4G5G and 5G5G genotypes. We assessed the time of onset of symptoms in 623 consecutive patients with acute myocardial infarction (AMI) enrolled in the MISSION! Study between February 1, 2004, and October 29, 2006. All of the patients were genotyped for the PAI-1 4G/5G polymorphism. We quantified the amplitude of the 24h variation of AMI with a generalized linear model with Poisson distribution. A morning peak, between 06:00-11:59h (n = 197; 32% of all cases), in the onset of symptoms of AMI was observed. The group composed of patients with the 4G4G genotype did not have a more pronounced morning peak than the groups composed of other genotypes; the 24h variation was 38% (95% confidence interval 12-70%) in the group of 4G4G patients and 34% (14-58%) and 56% (20-100%) in the 4G5G and 5G5G groups of patients, respectively. Our findings show that 24h variation of cardiac risk is not more pronounced among the 4G4G genotype of PAI-1. (Author correspondence: j.g.vanderbom@lumc.nl).
引用
收藏
页码:637 / 652
页数:16
相关论文
共 46 条
[1]   Task force 1: The ACCF and AHA codes of conduct in human subjects research [J].
Adams, RJ ;
Antman, EM ;
Kavey, REW .
CIRCULATION, 2004, 110 (16) :2512-2516
[2]  
ANDREASEN PA, 1986, J BIOL CHEM, V261, P7644
[3]   CIRCADIAN VARIATION OF FIBRINOLYTIC-ACTIVITY IN BLOOD [J].
ANDREOTTI, F ;
KLUFT, C .
CHRONOBIOLOGY INTERNATIONAL, 1991, 8 (05) :336-351
[4]   DIURNAL-VARIATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND ITS RAPID INHIBITOR (PAI-1) [J].
ANGLETON, P ;
CHANDLER, WL ;
SCHMER, G .
CIRCULATION, 1989, 79 (01) :101-106
[5]  
[Anonymous], AM HEART J
[6]   Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosis [J].
Berry, CN ;
Lunven, C ;
Lechaire, I ;
Girardot, C ;
O'Connor, SE .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (01) :29-34
[7]   THROMBOLYSIS AND REOCCLUSION IN EXPERIMENTAL JUGULAR-VEIN AND CORONARY-ARTERY THROMBOSIS - EFFECTS OF A PLASMINOGEN-ACTIVATOR INHIBITOR TYPE 1-NEUTRALIZING MONOCLONAL-ANTIBODY [J].
BIEMOND, BJ ;
LEVI, M ;
CORONEL, R ;
JANSE, MJ ;
TENCATE, JW ;
PANNEKOEK, H .
CIRCULATION, 1995, 91 (04) :1175-1181
[8]   PLASMINOGEN-ACTIVATOR INHIBITOR FROM HUMAN-ENDOTHELIAL CELLS - PURIFICATION AND PARTIAL CHARACTERIZATION [J].
BOOTH, NA ;
MACGREGOR, IR ;
HUNTER, NR ;
BENNETT, B .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 165 (03) :595-600
[9]   LYSIS OF PLATELET-RICH THROMBI - THE ROLE OF PAI-1 [J].
BOOTH, NA ;
ROBBIE, LA ;
CROLL, AM ;
BENNETT, B .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 667 :70-80
[10]   Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III registry and TIMI IIIB) [J].
Cannon, CP ;
McCabe, CH ;
Stone, PH ;
Schactman, M ;
Thompson, B ;
Theroux, P ;
Gibson, RS ;
Feldman, T ;
Kleiman, NS ;
Tofler, GH ;
Muller, JE ;
Chaitman, BR ;
Braunwald, E .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (03) :253-258